FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
FORTEO
teriparatide
LOE Approaching
Eli Lilly and Company
SUBCUTANEOUS · SOLUTION
women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mggreater of prednisone) at high risk for fracture
2002
PeptideNDA30/100
FORTESTA
testosterone
LOE Approaching
TRANSDERMAL · GEL, METERED
2010
NDA30/100
FORTICAL
calcitonin salmon recombinant
LOE Approaching
NASAL · SPRAY, METERED
2005
NDA30/100
FORTOVASE
saquinavir
LOE Approaching
Roche
ORAL · CAPSULE
1997
SMNDA30/100
FOSAMAX
alendronate sodium
LOE Approaching
Merck & Co.
ORAL · SOLUTION
2003
NDA30/100
FOSAMAX
alendronate sodium
LOE Approaching
Merck & Co.
ORAL · TABLET
osteoporosis in postmenopausal womenpostmenopausal osteoporosis [see]+7
1995
NDA30/100
FOSAMAX PLUS D
alendronate sodium and cholecalciferol
LOE Approaching
Merck & Co.
ORAL · TABLET
osteoporosis in postmenopausal women
2005
NDA30/100
FOSCAVIR
foscarnet sodium
LOE Approaching
INTRAVENOUS · SOLUTION
CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients
1991
NDA30/100
FOSRENOL
lanthanum carbonate
LOE Approaching
Takeda
ORAL · TABLET, CHEWABLE
serum phosphate in patients with end-stage renal disease (ESRD)
2004
NDA30/100
FRAGMIN
dalteparin sodium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
non-Q-wave myocardial infarction () • Prophylaxis of deep vein thrombosis (DVT) in abdominal surgeryhip replacement surgery+5
1994
NDA30/100
FREAMINE 8.5%
amino acids
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE HBC 6.9%
amino acids
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE II 8.5%
amino acids
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE III 10%
amino acids
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE III 3% W/ ELECTROLYTES
amino acids; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE III 8.5%
amino acids
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FREAMINE III 8.5% W/ ELECTROLYTES
amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1971
NDA30/100
FROVA
frovatriptan succinate
LOE Approaching
ORAL · TABLET
2001
NDA30/100
FUDR
floxuridine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1970
NDA30/100
FUNDUSCEIN-25
fluorescein sodium
LOE Approaching
Novartis
INJECTION · INJECTABLE
1976
NDA30/100
FUNGIZONE
amphotericin b
LOE Approaching
Bristol Myers Squibb
TOPICAL · CREAM
1966
NDA30/100
FUNGIZONE
amphotericin b
LOE Approaching
Bristol Myers Squibb
ORAL · SUSPENSION
1971
NDA30/100
FUNGIZONE
amphotericin b
LOE Approaching
Bristol Myers Squibb
TOPICAL · OINTMENT
1965
NDA30/100
FURACIN
nitrofurazone
LOE Approaching
Takeda
TOPICAL · OINTMENT
1945
NDA30/100